FLGA Podcast Ep 6: Christine Simmon of AAM and the Biosimilars Council by Frier Levitt Government Affairs published on 2019-06-27T15:51:26Z In this episode of the Frier Levitt Government Affairs Podcast, Ron Lanton interviews Christine Simmon, Senior Vice President, Policy & Strategic Alliances of the Association for Accessible Medicines and Executive Director of the Biosimilars Council. They discuss: • The Association for Accessible Medicines (AAM) • AAM’s work towards greater patient access to Biosimilars • The Specialty market place and the evolution towards Biosimilars • Greater Biosimilar utilization • Biosimilars and drug pricing • Interchangeability • Value Based Payments • FDA Naming Conventions • The Purple Book Legislation Genre Pharmacy
